Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Deramaxx Chewable Tablets Patent Expiration

Deramaxx Chewable Tablets is a drug owned by ELANCO US INC. It is protected by 4 US drug patents filed from 2015 to 2016. All patents have expired. Details of Deramaxx Chewable Tablets’s patents and their expiration are given below.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Patent Number Drug Patent Expiry Status
Patent Data
US5892053 25 May, 2015 Expired
US5910597 25 May, 2015 Expired

Exclusivity Information

Deramaxx Chewable Tablets holds 1 exclusivity out of which 1 has expired. Details of Deramaxx Chewable Tablets's exclusivity codes and their expiration dates are given below.

Drug Exclusivity Drug Exclusivity Expiration
NCI Nov 23, 2014

Deramaxx Chewable Tablets Petitions

Details of Deramaxx Chewable Tablets's suitability petitions are listed below.

Petitioner Action Date of Action Description
Petitions Data
Piedmont Animal Health Approved NA

About Deramaxx Chewable Tablets

Deramaxx Chewable Tablets is a drug owned by ELANCO US INC. Deramaxx Chewable Tablets uses Deracoxib as the active ingredient.

Active Ingredient:

Deramaxx Chewable Tablets uses Deracoxib as the active ingredient. Check out other Drugs and Companies using Deracoxib ingredient.